Roivant Sciences (ROIV) Return on Sales (2020 - 2025)
Roivant Sciences (ROIV) posted Return on Sales of 0.13% for Q3 2025, up 37.49% on a QoQ basis from 0.09% in Q2 2025, and up 22.0% year-over-year from 0.1% in Q3 2024.
Roivant Sciences (ROIV) Return on Sales (2020 - 2025) Analysis & Trends
Roivant Sciences' Return on Sales history runs 6 years deep, the most recent figure standing at 0.13% for Q3 2025.
- Quarterly Return on Sales rose 22.0% year-over-year to 0.13% in Q3 2025, while the trailing twelve-month figure through Sep 2025 was 0.13% (up 17.0% YoY) and the FY2025 annual result came in at 0.13%, up 22.0% from the prior year.
- Return on Sales was 0.13% for Q3 2025 at Roivant Sciences, up from 0.09% in the prior quarter.
- Across five years, Return on Sales topped out at 0.17% in Q4 2024 and bottomed at 0.82% in Q2 2022.
- A 5-year average of 0.13% and a median of 0.13% in 2021 frame the typical range for Return on Sales.
- Annual changes were most pronounced in 2022 — Return on Sales sank 69 bps — and 2023, when it surged 67 bps.
- Roivant Sciences' Return on Sales stood at 0.14% in 2021, then tumbled by 126 bps to 0.31% in 2022, then jumped by 69 bps to 0.1% in 2023, then surged by 282 bps to 0.17% in 2024, then dropped by 28 bps to 0.13% in 2025.
- Business Quant data shows ROIV's Return on Sales at 0.13% in Q3 2025, 0.09% in Q2 2025, and 0.17% in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.00% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 0.00% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.00% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 0.00% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Roivant Sciences | 24.35 Bn | 25.12 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 0.13% |
| Jun 30, 2025 | 0.09% |
| Dec 31, 2024 | 0.17% |
| Sep 30, 2024 | -0.10% |
| Jun 30, 2024 | 0.11% |
| Dec 31, 2023 | -0.10% |
| Sep 30, 2023 | -0.24% |
| Jun 30, 2023 | -0.15% |
| Dec 31, 2022 | -0.31% |
| Sep 30, 2022 | -0.25% |
| Jun 30, 2022 | -0.82% |
| Dec 31, 2021 | -0.14% |
| Sep 30, 2021 | -0.16% |
| Jun 30, 2021 | -0.13% |
| Dec 31, 2020 | -0.48% |
| Sep 30, 2020 | -0.40% |
| Jun 30, 2020 | -0.05% |